Active Chemistry Computing & AI

ZeroShotAPI: Using ZeroShot Machine Learning and an automated HTE reactor to derive universal chemical reaction condition parameters for Active Pharmaceutical Ingredients.

In plain English

AI plain-English summary

Making a new drug is like trying to bake a perfect cake when you don’t know the oven temperature, baking time, or even which ingredients to combine. This project builds a software platform that uses machine learning and an automated chemical reactor to figure out the ideal conditions—temperature, solvent, catalyst—for manufacturing active pharmaceutical ingredients (APIs) in a single shot, without trial-and-error guesswork. Currently, chemists often run hundreds of small experiments to find the right reaction conditions for each new drug molecule. That process is slow, expensive, and generates chemical waste. The platform aims to replace this with a universal set of parameters that work across many different reactions, learned from high-throughput experiments and proprietary data. If successful, the platform could slash the time and cost of bringing a new drug to market. It would also make pharmaceutical manufacturing more sustainable by reducing the solvents, energy, and raw materials wasted in failed reactions. For the public, this means cheaper medicines and a smaller environmental footprint from the factories that produce them. The project is applied, not fundamental science—it directly targets a bottleneck in industrial drug production.

View original technical description
This project aims to develops a software platform combining sophisticated Machine Learning approaches and proprietary data from a High Throughput Experimentation reactor to derive universal chemical reaction condition parameters to optimise the sustainable manufacturing of Active Pharmaceutical Ingredients.

View the original record at the funder ↗

Related Research

Grants with similar aims, by meaning.

Machine Learning Driven Reaction Screening in Continuous Flow
Accelerating Net Zero Manufacturing with Intelligent Optical Reactor Technology
Integrated Self-Optimisation of API Synthesis and Crystallisation Using Machine-Learning
Development of a machine learning-assisted digital twin platform for real-time optimisation of reaction systems under uncertainty
Accelerated Development of Pharmaceutical Processes Through Digitally Coupled Reaction Screening and Process Optimisation

Original classification

Collaborative R&D

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.